Breaking News
May 3, 2019 - Vaping and Smoking May Signal Greater Motivation to Quit
May 3, 2019 - Dementia looks different in brains of Hispanics
May 3, 2019 - Short-Staffed Nursing Homes See Drop In Medicare Ratings
May 3, 2019 - Study of teens with eating disorders explores how substance users differ from non-substance users
May 3, 2019 - Scientists develop new video game that may help in the study of Alzheimer’s
May 3, 2019 - Arc Bio introduces Galileo Pathogen Solution product line at ASM Clinical Virology Symposium
May 3, 2019 - Cornell University study uncovers relationship between starch digestion gene and gut bacteria
May 3, 2019 - How to Safely Use Glucose Meters and Test Strips for Diabetes
May 3, 2019 - Anti-inflammatory drugs ineffective for prevention of Alzheimer’s disease
May 3, 2019 - Study tracks Pennsylvania’s oil and gas waste-disposal practices
May 3, 2019 - Creating a better radiation diagnostic test for astronauts
May 3, 2019 - Vegans are often deficient in these four nutrients
May 3, 2019 - PPDC announces seed grants to develop medical devices for children
May 3, 2019 - Study maps out the frequency and impact of water polo head injuries
May 3, 2019 - Research on Reddit identifies risks associated with unproven treatments for opioid addiction
May 3, 2019 - Good smells may help ease tobacco cravings
May 3, 2019 - Medical financial hardship found to be very common among people in the United States
May 3, 2019 - Researchers develop multimodal system for personalized post-stroke rehabilitation
May 3, 2019 - Study shows significant mortality benefit with CABG over percutaneous coronary intervention
May 3, 2019 - Will gene-editing of human embryos ever be justifiable?
May 3, 2019 - FDA Approves Dengvaxia (dengue vaccine) for the Prevention of Dengue Disease in Endemic Regions
May 3, 2019 - Why Tonsillitis Keeps Coming Back
May 3, 2019 - Fighting the opioid epidemic with data
May 3, 2019 - Maggot sausages may soon be a reality
May 3, 2019 - Deletion of ATDC gene prevents development of pancreatic cancer in mice
May 2, 2019 - Targeted Therapy Promising for Rare Hematologic Cancer
May 2, 2019 - Alzheimer’s disease is a ‘double-prion disorder,’ study shows
May 2, 2019 - Reservoir bugs: How one bacterial menace makes its home in the human stomach
May 2, 2019 - Clinical, Admin Staff From Cardiology Get Sneak Peek at Epic
May 2, 2019 - Depression increases hospital use and mortality in children
May 2, 2019 - Vicon and NOC support CURE International to create first gait lab in Ethiopia
May 2, 2019 - Researchers use 3D printer to make paper organs
May 2, 2019 - Viral infection in utero associated with behavioral abnormalities in offspring
May 2, 2019 - U.S. Teen Opioid Deaths Soaring
May 2, 2019 - Opioid distribution data should be public
May 2, 2019 - In the Spotlight: “I’m learning every single day”
May 2, 2019 - 2019 Schaefer Scholars Announced
May 2, 2019 - Podcast: KHN’s ‘What The Health?’ Bye-Bye, ACA, And Hello ‘Medicare-For-All’?
May 2, 2019 - Study describes new viral molecular evasion mechanism used by cytomegalovirus
May 2, 2019 - SLU study suggests a more equitable way for Medicare reimbursement
May 2, 2019 - Scientists discover first gene involved in lower urinary tract obstruction
May 2, 2019 - Researchers identify 34 genes associated with increased risk of ovarian cancer
May 2, 2019 - Many low-income infants receive formula in the first few days of life, finds study
May 2, 2019 - Global study finds high success rate for hip and knee replacements
May 2, 2019 - Taking depression seriously: What is it?
May 2, 2019 - With Head Injuries Mounting, Will Cities Put Their Feet Down On E-Scooters?
May 2, 2019 - Scientists develop small fluorophores for tracking metabolites in living cells
May 2, 2019 - Study casts new light into how mothers’ and babies’ genes influence birth weight
May 2, 2019 - Researchers uncover new brain mechanisms regulating body weight
May 2, 2019 - Organ-on-chip systems offered to Asia-Pacific regions by Sydney’s AXT
May 2, 2019 - Adoption of new rules drops readmission penalties against safety net hospitals
May 2, 2019 - Kids and teens who consume zero-calorie sweetened beverages do not save calories
May 2, 2019 - Improved procedure for cancer-related erectile dysfunction
May 2, 2019 - Hormone may improve social behavior in autism
May 2, 2019 - Alzheimer’s disease may be caused by infectious proteins called prions
May 2, 2019 - Even Doctors Can’t Navigate Our ‘Broken Health Care System’
May 2, 2019 - Study looks at the impact on criminal persistence of head injuries
May 2, 2019 - Honey ‘as high in sugars as table sugar’
May 2, 2019 - Innovations to U.S. food system could help consumers in choosing healthy foods
May 2, 2019 - FDA Approves Mavyret (glecaprevir and pibrentasvir) as First Treatment for All Genotypes of Hepatitis C in Pediatric Patients
May 2, 2019 - Women underreport prevalence and intensity of their own snoring
May 2, 2019 - Concussion summit focuses on science behind brain injury
May 2, 2019 - Booker’s Argument For Environmental Justice Stays Within The Lines
May 2, 2019 - Cornell research explains increased metastatic cancer risk in diabetics
May 2, 2019 - Mount Sinai study provides fresh insights into cellular pathways that cause cancer
May 2, 2019 - Researchers to study link between prenatal pesticide exposures and childhood ADHD
May 2, 2019 - CoGEN Congress 2019: Speakers’ overviews
May 2, 2019 - A new strategy for managing diabetic macular edema in people with good vision
May 2, 2019 - Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP, 60mg/2mL (30mg per mL) Due to Lack of Sterility Assurance
May 2, 2019 - Screen time associated with behavioral problems in preschoolers
May 2, 2019 - Hormone reduces social impairment in kids with autism | News Center
May 2, 2019 - Researchers synthesize peroxidase-mimicking nanozyme with low cost and superior catalytic activity
May 2, 2019 - Study results of a potential drug to treat Type 2 diabetes in children announced
May 2, 2019 - Multigene test helps doctors to make effective treatment decisions for breast cancer patients
May 2, 2019 - UNC School of Medicine initiative providing unique care to dementia patients
May 2, 2019 - Nestlé Health Science and VHP join forces to launch innovative COPES program for cancer patients
May 2, 2019 - Study examines how our brain generates consciousness and loses it during anesthesia
May 2, 2019 - Transition Support Program May Aid Young Adults With Type 1 Diabetes
May 2, 2019 - Study shows how neutrophils exacerbate atherosclerosis by inducing smooth muscle-cell death
May 2, 2019 - Research reveals complexity of how we make decisions
Predicting whether a patient will benefit from chemotherapy

Predicting whether a patient will benefit from chemotherapy

Case Western Reserve University researchers and partners, including a collaborator at Cleveland Clinic, are pushing the boundaries of how “smart” diagnostic-imaging machines identify cancers–and uncovering clues outside the tumor to tell whether a patient will respond well to chemotherapy.

The recent findings in breast and lung cancer research build off work pioneered by biomedical engineering professor Anant Madabhushi, founder of the Center for Computational Imaging and Personalized Diagnostics. He is senior author on a pair of recent journal publications and joined by scientists from the Case School of Engineering, Cleveland Clinic and New York University Langone Medical Center.

This work, in total, heralds a more personalized future in medical diagnoses, Madabhushi said.

“And it is further evidence that information gleaned by computational interrogation of the region outside the tumors on MRI (magnetic resonance images) and CAT (computed tomography) scans is extremely valuable and can predict response and benefit of chemotherapy in lung and breast cancer patients,” said Madabhushi, the F. Alex Nason Professor II of Biomedical Engineering at the Case School of Engineering.

Madabhushi founded the center in 2012 and has more than 50 collaborators working on related projects. The lab has become a global leader in the detection, diagnosis and characterization of various cancers and other diseases by meshing medical imaging, machine learning and artificial intelligence.

Hope for HER2 breast cancer

The most recent research–published April 19 in JAMA Network Open–focuses on markers on tissue outside a breast tumor that can indicate whether a patient will respond to targeted chemotherapy.

Biomedical Engineering doctoral researcher Nathaniel Braman and medical school faculty member Vinay Varadan led a team of collaborators who reported discovery of a previously hidden “signature” associated with one type of breast cancer, known as HER2-positive (or simply HER2). It comprises about 20% of all cases and receives a special targeted treatment strategy.

The researchers have been able to classify the patients with HER2 breast cancer into molecular subtypes–corresponding to those who will likely respond to targeted chemotherapy and those who won’t–simply by analyzing an initial tissue sample.

The work “provides insights into the ability of radiomic analyses to capture clinically-significant tumor biology,” explained Varadan, a co-senior author on the study with Madabhushi. It “justifies additional studies to assess the clinical utility of such noninvasive approaches to guide therapeutic strategies in this disease.”

The markers are not found on images made from tissue slides, but outside the tumor itself. They cannot be seen by the human eye, but are revealed by a process known as radiomics, which extracts relevant data from medical images like MRIs.

“Right now, these patients receive ‘one-size-fits-all’ treatment despite being quite diverse,” Braman said. “What we’re trying to do here is identify before treatment which patients will actually benefit from specific therapies. This could give doctors and patients information they did not have before.”

Putting the idea into use is probably years away, following clinical trials and then the big step of someday “getting doctors to be able to trust and use it,” Braman said.

To that end, the researchers wrote that they explored the overlap between their imaging signature and information from the tissue slides and genetics that doctors consider important in treatment decisions.

Radiomics of region outside lung nodule predicts benefit of chemotherapy

The other study, published in March, also evaluates whether computer-extracted image patterns (or radiomics) outside a tumor can indicate whether a lung cancer patient will respond to targeted chemotherapy.

“The problem at the start is that only one in four lung cancer patients will respond favorably to chemotherapy, but virtually everyone gets that treatment,” said biomedical engineering doctoral researcher Mohammadhadi Khorrami, one of the leaders of the research. “But all of the previous research has been limited to inside the tumor.”

In this case, the researchers examined image data from 125 Cleveland Clinic patients diagnosed with non-small cell lung cancer (NSCLC). All had previously received targeted chemotherapy, but only about half had responded to the difficult treatment.

Using the information gleaned from those patients’ data, researchers trained their technology to distinguish between image data of patients who had responded and those who had not. Then they tested the technology against additional patient data.

“By looking both inside and outside the tumor,” Khorrami said, “we achieved an accuracy of 77% in determining which patients would benefit from chemotherapy–far better (68%) than just looking at the tumor itself.”

Khorrami was the first author of a team of 10 researchers who published the research with Monica Khunger, a Cleveland Clinic physician at the time of the study, now employed by UPMC in Pittsburgh.) Their work appeared in March in the journal Radiology: Artificial Intelligence.

Using radiomics, researchers can extract quantitative, or measurable, data from CT images that can reveal disease characteristics not visible in the images alone, according to a Radiological Society of America’s news release on the research.

“This can change the game, not only for the patient when it comes to outcome, but when it comes to cost overall for the health-care field,” Khorrami said. “It costs about $30,000 or more a year for chemotherapy, so it’s important to know who will respond to chemotherapy, and we’re getting closer to a true biomarker to do that.”

Tagged with:

About author

Related Articles